Literature DB >> 7125737

Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.

S A Wells, S B Baylin, I S Johnsrude, D P Harrington, G Mendelsohn, D J Ontjes, C W Cooper.   

Abstract

In kindreds with familial medullary thyroid carcinoma (MTC), individuals are often detected whose peripheral plasma calcitonin (CT) levels are undetectable in the basal state but increase minimally following provocative testing. The proper management of such patients has been uncertain, but most investigators have advocated repeat testing and evaluation after an interval of several months. The present study was conducted to evaluate the diagnostic implications of these modest increases in plasma calcitonin. In 25 kindred members at direct risk for familial medullary thyroid carcinoma (MTC), basal peripheral plasma calcitonin (CT) levels were less than 240 pg/ml. Following provocative testing with intravenous calcium or pentagastrin or both, calcitonin values remained below 240 pg/ml in eight subjects (Group A), however, they were mildly elevated (260-580 pg/ml) in 12 subjects (Group B) and moderately elevated (700-940 pg/ml) in five subjects (Group C). Following the transfemoral placement of a catheter into the inferior thyroid vein (ITV), provocative testing was repeated, and ITV and peripheral blood samples were collected simultaneously. Basal ITV plasma CT levels were below 240 pg/ml in all patients in Group A, however, they were mildly elevated (500 pg/ml) in one of the 12 patients in Group B and moderately elevated (800 pg/ml, 1400 pg/ml) in two of the five patients in Group C. Following provocation, ITV plasma CT levels became markedly elevated in one patient in Group A and in all of the patients in Groups B(2520+/-635 pg/ml) and C (6322+/-2598 pg/ml). Thyroidectomy was performed in patients whose ITV plasma CT level was elevated following provocative testing. Medullary thyroid carcinoma of C-cell hyperplasia were evident either on microscopic (1/1 patient in Group A;9/12 patients in Group B; and 2/5 patients in Group C), or gross (3/12 patients in Group B;3/5 patients in Group C) examination of thyroidectomy specimens. In only one of 14 patients was metastatic MTC noted on histologic examination of resected cervical lymph nodes. Postoperative peripheral plasma CT levels were unchanged from basal and less than 240 pg/ml following provocative testing in all but one patient. The present study then provides definitive evidence that patients at direct risk for familial MTC who have even minimally abnormal responses in peripheral plasma CT following provocative testing generally harbor some stage of a C-cell proliferative disorder. Identification of such individuals with early disease is important because thyroidectomy offers an extremely high cure rate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7125737      PMCID: PMC1352780          DOI: 10.1097/00000658-198211000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Detection of medullary thyroid cancer by calcitonin assay in families.

Authors:  C E Jackson; A H Tashjian; M A Block
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

2.  A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid.

Authors:  J F Hennessy; S A Wells; D A Ontjes; C W Cooper
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

3.  A short calcium infusion in the diagnosis of medullary thyroid carcinoma.

Authors:  J G Parthemore; D Bronzert; G Roberts; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

4.  Immunoreactive calcitonin in medullary carcinoma of the thyroid and in maternal and cord serum.

Authors:  N A Samaan; C S Hill; J R Beceiro; P N Schultz
Journal:  J Lab Clin Med       Date:  1973-05

5.  Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay.

Authors:  K E Melvin; H H Miller; A H Tashjian
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

6.  Immunoassay for human calcitonin. I. Method.

Authors:  L J Deftos
Journal:  Metabolism       Date:  1971-12       Impact factor: 8.694

7.  Calcitonin levels in thyroid-vein blood of man.

Authors:  O L Silva; K L Becker; J L Doppman; R H Snider; C F Moore
Journal:  Am J Med Sci       Date:  1975 Jan-Feb       Impact factor: 2.378

8.  Immunoassay for human calcitonin. II. Clinical studies.

Authors:  L J Deftos; A E Bury; J F Habener; F R Singer; J T Potts
Journal:  Metabolism       Date:  1971-12       Impact factor: 8.694

9.  Basal and pentagastrin-stimulated levels of calcitonin in thyroid and peripheral veins during normocalcemia and chronic hypercalcemia in humans.

Authors:  M Ericsson; M Berg; S Ingemansson; B Jernby; J Järhult
Journal:  Ann Surg       Date:  1981-08       Impact factor: 12.969

10.  The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase.

Authors:  S M Lippman; G Mendelsohn; D L Trump; S A Wells; S B Baylin
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

View more
  3 in total

Review 1.  Multiple endocrine neoplasia.

Authors:  R A Decker; S A Wells
Journal:  Jpn J Surg       Date:  1989-11

2.  (131I)meta-iodobenzylguanidine scintigraphy and selective venous catheterization after thyroidectomy for medullary thyroid carcinoma.

Authors:  G Lupoli; G Lombardi; N Panza; B Biondi; G Pacilio; S Lastoria; M Salvatore
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

3.  Importance of early diagnosis and follow-up in multiple endocrine neoplasia (MEN II B).

Authors:  K Frank; F Raue; J Gottswinter; U Heinrich; H Meybier; R Ziegler
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.